Presentation is loading. Please wait.

Presentation is loading. Please wait.

Gene Patenting Web Quest Law Meets Bioethics Katie Horne Marshfield High School Biology.

Similar presentations


Presentation on theme: "Gene Patenting Web Quest Law Meets Bioethics Katie Horne Marshfield High School Biology."— Presentation transcript:

1

2 Gene Patenting Web Quest Law Meets Bioethics Katie Horne Marshfield High School Biology

3 Gene Patents and Immunology?? Aspects of immunology embedded in another topic. Aspects of immunology embedded in another topic. Gene Patenting is a new development. Gene Patenting is a new development. Student enthusiasm. Student enthusiasm.

4 The Cases John Moore and his amazing spleen John Moore and his amazing spleen Erich Fuchs and Steve Crohn: HIV immunity and the plague connection Erich Fuchs and Steve Crohn: HIV immunity and the plague connection Daniel Greenberg and the tragedy of Canavan Disease Daniel Greenberg and the tragedy of Canavan Disease The Terry’s get smart when it comes to patent law The Terry’s get smart when it comes to patent law The (unfair?) treatment of Arupa Ganguly, PhD. The (unfair?) treatment of Arupa Ganguly, PhD.

5 John Moore and His Amazing Spleen The diagnosis The diagnosis Dr. Golde takes a special interest Dr. Golde takes a special interest The Biotech companies jump in The Biotech companies jump in Where does that leave Mr. Moore? Where does that leave Mr. Moore?

6 HIV “Immunity” Erich Fuchs and Steve Crohn are born lucky Erich Fuchs and Steve Crohn are born lucky The Aaron Diamond Institute The Aaron Diamond Institute CCR5 delta 32 CCR5 delta 32 People with European descent are more likely to have CCR5 delta 32 People with European descent are more likely to have CCR5 delta 32

7 The Tragedy of the Greenbergs Diagnosis: Canavan Disease Diagnosis: Canavan Disease Tissue samples, recruited patients, $$$ Tissue samples, recruited patients, $$$

8 The Foresight of the Terry’s Diagnosis: Pseudoxanthoma elasticum Diagnosis: Pseudoxanthoma elasticum Tissue samples, recruited patients, $$$, AND A Signed Contract! Tissue samples, recruited patients, $$$, AND A Signed Contract!

9 Arupa Ganguly, PhD. BRCA 1 and 2 Testing BRCA 1 and 2 Testing Myriad Genetics Myriad Genetics Winners: Myriad Losers: The public? Winners: Myriad Losers: The public?

10 The Law The role of patents in research The role of patents in research Rules of the genetic game Rules of the genetic game 20 year monopoly 20 year monopoly

11 PRO: Researchers are rewarded for their discoveries and can use monies gained from patenting to further their research. The investment of resources is encouraged by providing a monopoly to the inventor and prohibiting competitors from making, using, or selling the invention without a license. Wasteful duplication of effort is prevented. Research is forced into new, unexplored areas. Secrecy is reduced and all researchers are ensured access to the new invention CON: Patents of partial and uncharacterized cDNA sequences will reward those who make routine discoveries but penalize those who determine biological function or application (inappropriate reward given to the easiest step in the process). Patents could impede the development of diagnostics and therapeutics by third parties because of the costs associated with using patented research data. Patent stacking (allowing a single genomic sequence to be patented in several ways such as an EST, a gene, and a SNP) may discourage product development because of high royalty costs owed to all patent owners of that sequence; these are costs that will likely be passed on to the consumer. Because patent applications remain secret until granted, companies may work on developing a product only to find that new patents have been granted along the way, with unexpected licensing costs and possible infringement penalties. Costs increase not only for paying for patent licensing but also for determining what patents apply and who has rights to downstream products. Patent holders are being allowed to patent a part of nature --a basic constituent of life; this allows one organism to own all or part of another organism. Private biotechs who own certain patents can monopolize certain gene test markets. Patent filings are replacing journal articles as places for public disclosure --reducing the body of knowledge in the literature.

12 Bioinformatics The ABC’s The ABC’s HIV and the CCR5 delta 32 mutation HIV and the CCR5 delta 32 mutation Using NCBI, find the nucleotide difference Using NCBI, find the nucleotide difference Special thanks to Dave Form Special thanks to Dave Form

13 The Actual Patents http://dnapatents.georgetown.edu/ostext/5 679635.htm http://dnapatents.georgetown.edu/ostext/5 679635.htm http://dnapatents.georgetown.edu/ostext/5 679635.htm http://dnapatents.georgetown.edu/ostext/5 679635.htm http://dnapatents.georgetown.edu/ostext/5 753441.htm http://dnapatents.georgetown.edu/ostext/5 753441.htm http://dnapatents.georgetown.edu/ostext/5 753441.htm http://dnapatents.georgetown.edu/ostext/5 753441.htm

14 Additional Resources Do Your Cells Belong to You? Do Your Cells Belong to You? To Own or Not to Own DNA To Own or Not to Own DNA


Download ppt "Gene Patenting Web Quest Law Meets Bioethics Katie Horne Marshfield High School Biology."

Similar presentations


Ads by Google